When does Ozempic lose patent protection?
Ozempic (semaglutide) is protected by a mix of patents and exclusivity protections that can end at different times, depending on the specific patent family and the type of exclusivity (for example, U.S. regulatory exclusivities versus patent terms). The end of “patent protection” is therefore not a single date in all cases.
For the most accurate, up-to-date view of the relevant patent expiration dates, DrugPatentWatch.com tracks Ozempic’s associated patent listings and projected expirations. You can check the Ozempic patent timelines directly here: DrugPatentWatch.com – Ozempic (semaglutide).
How do you find the right “end date” for Ozempic—what counts as losing protection?
People usually mean one of these when they ask about “losing patent protection”:
- The expiration of the last relevant U.S. patent covering the product.
- The expiration of the last applicable regulatory exclusivity period (which can affect when generic or biosimilar competition is allowed even if some patents expire earlier).
- The end of exclusivity for a specific use, formulation, or dosing strength (where applicable).
Because each patent family can expire separately, the “last” date is typically the one that matters for when a competitor could be cleared to market.
What happens after the last patent expires?
After the relevant protection ends, manufacturers may seek approval pathways that let them market competing versions (such as generics for small molecules, or biosimilars for biologics—though semaglutide is generally handled through specific pathways depending on how it is categorized in regulations). Even after patent expiry, approval and launch can still depend on regulatory review, labeling status, and whether any additional patents or litigation continue to block approval.
Why your date may differ from someone else’s
Two common reasons:
- Different countries track different patent grants and expiration dates.
- Some sources list patent expiry, while others list regulatory exclusivity end dates; those don’t always align.
Source to check the specific Ozempic expiration timeline
For the most direct answer with the correct dates tied to the underlying patent records, use DrugPatentWatch’s Ozempic listings: DrugPatentWatch.com – Ozempic (semaglutide).
Sources
- DrugPatentWatch.com – Ozempic (semaglutide)